Latest Machine Learning News

WhiteHawk Limited has completed the first tranche of its capital raising, issuing over 135 million shares and raising A$1.56 million, with a second tranche pending shareholder approval in September.

ResMed Inc. reported a robust 10% increase in revenue to $5.15 billion for fiscal 2025, driven by strong demand in sleep and breathing health devices and residential care software. The company also expanded its diagnostic capabilities with the acquisition of VirtuOx, positioning itself for further growth in home-based health solutions.

X2M Connect Limited has completed a $309,000 entitlement offer by issuing 23.76 million new shares and options, while a substantial shortfall of nearly 127 million shares remains available for placement.

dorsaVi Ltd is expanding its RRAM technology evaluation to next-generation robotics, aiming to deliver sub-millisecond reflexes that could revolutionize safety and dexterity in collaborative robots and wearables.

Codeifai Limited advances its fintech and cybersecurity ambitions by acquiring a cutting-edge quantum-secure AI platform and a leading QR code competitor, backed by a $2.35 million capital raise.

PhosCo Ltd reports significant progress at its Gasaat Phosphate Project in Tunisia, unveiling promising drilling results and securing potential strategic investment from the EBRD to fund its next development phase.

TrivarX has secured key approvals and begun recruiting for its innovative mental health screening trial in US veterans, while also launching a wearable tech pilot with a Major League Baseball academy in the Dominican Republic.

Strategic Energy Resources has progressed key copper-gold projects in Queensland, securing government funding and advancing surveys with Fortescue, while divesting a non-core asset to sharpen its focus.

WhiteHawk Limited has completed a A$2 million share placement aimed at advancing its AI and machine learning automation capabilities and supporting new US cyber governance contracts.

4DMedical has renewed its three-year contract with the University of Michigan Medical Center, reinforcing its foothold in US respiratory imaging. Alongside, a pivotal clinical study validates its technology’s ability to detect early lung disease, while a substantial Australian grant boosts its AI research.

Ava Risk Group reports a 5% revenue increase and a positive EBITDA turnaround in FY25, underpinned by its advanced security technologies. The company eyes over $88 million in FY26 sales opportunities despite some project delays.

INOVIQ Limited reports strong clinical validation for its EXO-OC ovarian cancer screening test and promising preclinical results for CAR-exosome therapeutics targeting aggressive cancers.